guidelines for diagnosis and treatment of malaria in india-2009
DESCRIPTION
TRANSCRIPT
![Page 1: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/1.jpg)
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA
BY:Dr. AYESHA SARWAR.
![Page 2: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/2.jpg)
ACCORDING TO THE REVISED DRUG POLICY, THERE IS NO SCOPE OF PRESUMPTIVE TREATMENT IN MALARIA CONTROL.
THE RECOMMENDED GUIDELINES ARE DISCUSSED UNDER FOLLOWING 2 HEADINGS:
Treatment of uncomplicated malaria.
Treatment of severe malaria.
![Page 3: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/3.jpg)
A] TREATMENT OF
UNCOMPLICATED MALARIA
![Page 4: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/4.jpg)
All fever cases diagnosed as malaria by microscopy or RDT should promptly be given effective treatment.
![Page 5: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/5.jpg)
![Page 6: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/6.jpg)
RECOMMENDED TREATMENT SCHEDULE
![Page 7: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/7.jpg)
1.CHLOROQUINE FOR P.VIVAX & P.FALCIPARUM
AGE in years
DAY 1(10mg/kg)
DAY 2(10mg/kg)
DAY 3(5mg/kg)
<1 ½ ½ 1/4
1-4 1 1 ½
5-8 2 2 1
9-14 3 3 1 ½
15 &above
4 4 2
![Page 8: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/8.jpg)
2.PRIMAQUINE FOR P.VIVAX (DAILY DOSAGE FOR 14DAYS)
AGE(in years)
DAILY DOSAGE in mg base
NO. OF TABLETS(2.5 mg base)
<1 Nil Nil
1-4 2.5 1
5-8 5 2
9-14 10 4
15&above 15 6
![Page 9: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/9.jpg)
3.PRIMAQUINE FOR P.FALCIPARUM (SINGLE DOSE ON FIRST DAY)
AGE in years
DOSAGE(in mg base)
NO. OF TABLETS(7.5mg base)
<1 Nil 0
1-4 7.5 1
5-8 15 2
9-14 30 4
15 &above
45 6
![Page 10: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/10.jpg)
4.ARTEMISININ COMBINATION THERAPY (ACT- ARTESUNATE+SULFADOXINE+PYRIMETHAMINE) FOR P.FALCIPARUM
AGE in years
NO. OF TABLETS ON 1ST DAY
NO. OF TABLETS ON 2ND DAY
NO. OF TABLETS ON 3RD DAY
<1 AS SP
½¼
½Nil
½Nil
1-4 AS SP
11
1Nil
1Nil
5-8 AS SP
21 ½
2Nil
2Nil
9-14 AS SP
32
3nil
3nil
15 &above AS SP
43
4Nil
4nil
![Page 11: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/11.jpg)
AREAS THAT QUALIFY FOR THE ACT:
THEY ARE THE LISTED AREAS WITH HIGH P.falciparum ENDEMICITY IN SEVEN NORTH EASTERN STATES, AP, CHATTISGARH, JHARKHAND, MP & ORISSA.
117 DISTRICTS HAVE BEEN IDENTIFIED FOR THE ACT.
THE INDIVIDUALS WHO QUALIFY FOR THE ACT ARE:
A. THE PATIENTS WITH HISTORY OF TRAVEL TO THE LISTED AREAS
B. WHEN THERE IS NO CLINICAL OR PARASITOLOGICAL RESPONSE TO FULL DOSE OF CHLOROQUINE WITHIN 72hrs OF STARTING THERAPY.
![Page 12: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/12.jpg)
GENERAL RECOMMENDATIONS FOR THE MANAGEMENT OF UNCOMPLICATED MALARIA.
AVOID STARTING TREATMENT ON AN EMPTY STOMACH.
THE FIRST DOSE SHOULD BE GIVEN UNDER OBSERVATION.
DOSE SHOULD BE REPEATED IF VOMITING OCCURS WITHIN 30minutes.
THE PATIENT SHOULD REPORT BACK IF THERE IS NO IMPROVEMENT AFTER 48hrs.
THE PATIENT SHOULD ALSO BE EXAMINED FOR CONCOMITANT INFECTION.
![Page 13: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/13.jpg)
B] TREATMENT OF SEVERE MALARIA.
![Page 14: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/14.jpg)
CLINICAL FEATURES: IMPAIRED CONSIOUSNESS/COMA &
GENERALIZED CONVULSIONS. RENAL FAILURE (serum
creatinine>3mg/dl) JAUNDICE (serum bilirubin>3mg/dl) SEVERE ANEMIA(Hb< 5g/dl) PULMONARY EDEMA/ ACUTE
RESPIRATORY DISTRESS SYNDROME HYPOGLYCEMIA(plasma glucose<40
mg/dl). METABOLIC ACIDOSIS SHOCK(systolic BP<80mmHg) ABNOMAL BLEEDING & DIC HEMOGLOBINURIA HYPERTHERMIA. HYPERPARASITEMIA(<5% parasitized
RBCs)
![Page 15: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/15.jpg)
SPECIFIC ANTIMALARIAL TREATMENT OF SEVERE MALARIA
1] ARTESUNATE:2.4 mg/kg i.v or i.m..given on
admission time, then at 12hrs and 24hrs, then once a day.
(care should be taken to dilute artesunate with 5% sodium bicarbonate provided in the pack)
2] QUININE:20mg/kg i.v on admission followed
by maintainance dose of 10mg/kg 8hrly.
(never give bolus injection of quinine)
3]ARTEMETHER: 3.2mg/kg i.m on admission, then, 1.6mg/kg/day
4]ARTEETHER: 150mgdaily i.m for 3days in adults only.
![Page 16: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/16.jpg)
![Page 17: GUIDELINES FOR DIAGNOSIS AND TREATMENT OF MALARIA IN INDIA-2009](https://reader034.vdocuments.us/reader034/viewer/2022050801/548df1afb47959763e8b46aa/html5/thumbnails/17.jpg)